Volume 99, Issue 4

Search all Annals of Hematology articles

April 2020

32 articles in this issue

Evolving therapies for lower-risk myelodysplastic syndromes
Jan Philipp Bewersdorf
Amer M. Zeidan
Review Article 20 February 2020 Pages: 677 - 692
Updates on DNA methylation modifiers in acute myeloid leukemia
Bruna Contieri
Bruno Kosa Lino Duarte
Mariana Lazarini
Review Article 06 February 2020 Pages: 693 - 701
An update to the pathogenesis for monoclonal gammopathy of renal significance
Chao Zuo
Yuge Zhu
Gaosi Xu
Review Article 26 February 2020 Pages: 703 - 714
Mechanosensitive Piezo1 ion channel protein (PIEZO1 gene): update and extended mutation analysis of hereditary xerocytosis in India
Tejashree Anil More
Rashmi Dongerdiye
Prabhakar S. Kedar
Original Article 28 February 2020 Pages: 715 - 727
Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity
Nurul Fatihah Azman
Wan Zaidah Abdullah
Rosline Hassan
Original Article 20 February 2020 Pages: 729 - 735
Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency
Zesong Chen
Xinjian Liu
Bing Han
Original Article 06 February 2020 Pages: 737 - 741
Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study
Régis Peffault de Latour
Lynn Huynh
Mei Sheng Duh
Original Article 17 February 2020 Pages: 743 - 752
Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia
Si Chen
Xiang Li
Zhenyu Zhu
Original Article 04 February 2020 Pages: 753 - 763
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)
E. Bussaglia
M. Pratcorona
J. Nomdedéu
Original Article 15 February 2020 Pages: 765 - 772
Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome
B. Bouchacourt
M. A. Hospital
N. Vey
Original Article 22 February 2020 Pages: 773 - 780
Prevalence of pulmonary hypertension in myelofibrosis
Juan Lopez-Mattei
Srdan Verstovsek
Saadia A. Faiz
Original Article 19 February 2020 Pages: 781 - 789
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis
Alberto Alvarez-Larrán
Arturo Pereira
on behalf of GEMFIN and REHEVASC groups
Original Article 22 February 2020 Pages: 791 - 798
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
Mariana Bastos-Oreiro
Ana Muntañola
Armando López-Guillermo
Original Article 20 February 2020 Pages: 799 - 808
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia
Maximilian Schieck
Jana Lentes
Gudrun Göhring
Original Article Open access 20 February 2020 Pages: 809 - 818
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma
Do Young Kim
Joo-seop Chung
Ho-Jin Shin
Original Article 05 February 2020 Pages: 819 - 828
T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes
Shi Ting
Xie Mixue
Ye Xiujin
Original Article 27 February 2020 Pages: 829 - 834
Safety and efficacy of blinatumomab: a real world data
Arie Apel
Yishai Ofran
Maya Koren-Michowitz
Original Article 20 February 2020 Pages: 835 - 838
Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation
Sarita Rani Jaiswal
Paras Singhal
Suparno Chakrabarti
Original Article 05 February 2020 Pages: 839 - 845
IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Anna-Sophia Kattner
Ernst Holler
Daniel Wolff
Original Article Open access 21 February 2020 Pages: 847 - 853
High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience
Aleksandar Radujkovic
Ute Hegenbart
Thomas Luft
Original Article 08 February 2020 Pages: 855 - 866
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
Domenico Pastore
Benedetto Bruno
Francesca Bonifazi
Original Article 08 February 2020 Pages: 867 - 875
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay
Ana Carolina Oliver
Eloisa Riva
Pablo Muxi
Original Article 15 February 2020 Pages: 877 - 884
Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury
Keisuke Kidoguchi
Masako Yokoo
Shinya Kimura
Letter to the Editor 05 February 2020 Pages: 885 - 886
Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab
Fumiya Wada
Tadakazu Kondo
Akifumi Takaori-Kondo
Letter to the Editor 12 February 2020 Pages: 887 - 889
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes
Valentina Rosso
Jessica Petiti
Daniela Cilloni
Letter to the Editor 04 February 2020 Pages: 891 - 893
Plasmablastic IgM multiple myeloma with hypocellular bone marrow
Zhaohui Liao Arter
Daniel Miles
Joseph Roswarski
Letter to the Editor 14 February 2020 Pages: 895 - 896
Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report
Pierre-Edouard Debureaux
Anne Brignier
Marie Robin
Letter to the Editor 07 February 2020 Pages: 897 - 898
Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation
Verena Luber
Mathias Lutz
Stephan Mielke
Letter to the Editor Open access 22 February 2020 Pages: 899 - 901
Less ‘reds’ more ‘blues’: hemoglobin level and depression in non-transfusion-dependent thalassemia
Alexandra Monica Mihailescu
Khaled M. Musallam
Ali T. Taher
Letter to the Editor 21 February 2020 Pages: 903 - 904
Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible
R Soutar
M Steel
C Walbaum
Letter to the Editor 15 February 2020 Pages: 905 - 906
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm
Matteo Piccini
Giuseppe Gaetano Loscocco
Alberto Bosi
Letter to the Editor 07 February 2020 Pages: 907 - 909
The impact of statins on the intensity of phlebotomies in polycythemia vera
Ivan Krečak
Hrvoje Holik
Velka Gverić-Krečak
Letter to the Editor 05 February 2020 Pages: 911 - 912

Volume 99, Issue 4

Evolving therapies for lower-risk myelodysplastic syndromes

Updates on DNA methylation modifiers in acute myeloid leukemia

An update to the pathogenesis for monoclonal gammopathy of renal significance

Mechanosensitive Piezo1 ion channel protein (PIEZO1 gene): update and extended mutation analysis of hereditary xerocytosis in India

Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity

Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency

Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study

Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia

Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)

Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome

Prevalence of pulmonary hypertension in myelofibrosis

Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis

RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia

Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma

T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes

Safety and efficacy of blinatumomab: a real world data

Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience

Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs

Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay

Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury

Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes

Plasmablastic IgM multiple myeloma with hypocellular bone marrow

Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report

Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation

Less ‘reds’ more ‘blues’: hemoglobin level and depression in non-transfusion-dependent thalassemia

Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible

Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm

The impact of statins on the intensity of phlebotomies in polycythemia vera

Navigation